Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 2
2004 1
2005 2
2006 3
2007 4
2008 1
2009 1
2010 1
2011 1
2012 2
2013 2
2014 5
2015 1
2016 2
2017 1
2019 1
2020 3
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Ye D, Agerbaek M, Enting D, McDermott R, Gajate P, Peer A, Milowsky MI, Nosov A, Neif Antonio J Jr, Tupikowski K, Toms L, Fischer BS, Qureshi A, Collette S, Unsal-Kacmaz K, Broughton E, Zardavas D, Koon HB, Galsky MD. Bajorin DF, et al. Among authors: koon hb. N Engl J Med. 2021 Jun 3;384(22):2102-2114. doi: 10.1056/NEJMoa2034442. N Engl J Med. 2021. PMID: 34077643 Free PMC article. Clinical Trial.
Update on primary mucosal melanoma.
Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD, Gerstenblith MR. Tacastacas JD, et al. Among authors: koon hb. J Am Acad Dermatol. 2014 Aug;71(2):366-75. doi: 10.1016/j.jaad.2014.03.031. Epub 2014 May 6. J Am Acad Dermatol. 2014. PMID: 24815565 Review.
Current systemic therapies for melanoma.
Palathinkal DM, Sharma TR, Koon HB, Bordeaux JS. Palathinkal DM, et al. Among authors: koon hb. Dermatol Surg. 2014 Sep;40(9):948-63. doi: 10.1097/01.DSS.0000452626.09513.55. Dermatol Surg. 2014. PMID: 25072125 Review.
Anti-CD30 antibody-based therapy.
Koon HB, Junghans RP. Koon HB, et al. Curr Opin Oncol. 2000 Nov;12(6):588-93. doi: 10.1097/00001622-200011000-00012. Curr Opin Oncol. 2000. PMID: 11085459 Review.
Signal transduction targets in Kaposi's sarcoma.
Sullivan R, Dezube BJ, Koon HB. Sullivan R, et al. Among authors: koon hb. Curr Opin Oncol. 2006 Sep;18(5):456-62. doi: 10.1097/01.cco.0000239884.05914.13. Curr Opin Oncol. 2006. PMID: 16894293 Review.
FOXP1: a potential therapeutic target in cancer.
Koon HB, Ippolito GC, Banham AH, Tucker PW. Koon HB, et al. Expert Opin Ther Targets. 2007 Jul;11(7):955-65. doi: 10.1517/14728222.11.7.955. Expert Opin Ther Targets. 2007. PMID: 17614763 Free PMC article. Review.
Scurvy in a patient on vemurafenib.
Gerstenblith MR, Petukhova TA, Koon HB. Gerstenblith MR, et al. Among authors: koon hb. JAAD Case Rep. 2014 Nov 1;1(1):32-3. doi: 10.1016/j.jdcr.2014.10.008. eCollection 2015 Jan. JAAD Case Rep. 2014. PMID: 27075135 Free PMC article. No abstract available.
30 results